1695 East Southlake Boulevard Suite 150 Southlake , TX 76092 United StatesFEI 3041017461Issued Apr 1, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3041017461.
Violations1
Issue DateApr 1, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Pure Indulgence Aesthetics
Location
1695 East Southlake Boulevard Suite 150 Southlake , TX 76092 United States
FEI Number
3041017461
Country
United States
Issue Date
April 01, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
Drug Supply Chain Security Act (DSCSA) Violations
Pure Indulgence Aesthetics FDA Warning Letter, April 1, 2026
Talk to a Specialist